Skip to main content
. 2020 Jul 21;5(1):e000458. doi: 10.1136/bmjophth-2020-000458

Figure 1.

Figure 1

Treatment effects of CPFX and TETRA on cellular metabolism (figure 1A, B), ROS levels (figure 1C, D) and mitochondrial membrane potential (MMP, figure 1E, F) in ARPE-19 cells after 24, 48 and 72 hours as measured with the MTT, H2DCFDA and JC-1 assays. *P<0.05, **P<0.01. ARPE-19, human retinal pigment epithelial cells; CPFX, ciprofloxacin; H2DCFDA, 2’,7’-dichlorodihydrofluorescein diacetate; ns, not significant; ROS, reactive oxygen species; TETRA, tetracycline.